An Open-Label, First-In-Human, Study Evaluating The Safety, Tolerability, And Efficacy Of Vc-02 Combination Product In Subjects With Type 1 Diabetes Mellitus And Hypoglycemia Unawareness (Viacyte Vc02-101)
|Effective start/end date||12/1/16 → 12/31/23|
- VIACYTE, INC.
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.